| 12th Mar 2019 7:00 am |
RNS |
OXB announces R&D collaboration with Microsoft |
| 11th Mar 2019 10:38 am |
RNS |
Axovant's update on Phase 2 trial of AXO-Lenti-PD |
| 1st Mar 2019 9:30 am |
RNS |
Total Voting Rights |
| 25th Feb 2019 12:23 pm |
RNS |
Director Dealings / Market Share Purchase |
| 8th Feb 2019 7:00 am |
RNS |
Notice of Results |
| 7th Feb 2019 11:49 am |
RNS |
Director/PDMR Shareholding |
| 7th Feb 2019 9:22 am |
RNS |
Update on programmes outlicensed to Sanofi |
| 6th Feb 2019 11:00 am |
RNS |
Director Dealings / Market Share Transactions |
| 5th Feb 2019 10:22 am |
RNS |
Director Dealings / Market Share Purchase |
| 1st Feb 2019 10:00 am |
RNS |
Total Voting Rights |
| 24th Jan 2019 11:20 am |
RNS |
Director Dealings / Market Share Purchase |
| 3rd Jan 2019 12:20 pm |
RNS |
Block listing Interim Review |
| 2nd Jan 2019 10:17 am |
RNS |
Total Voting Rights |
| 21st Dec 2018 1:16 pm |
RNS |
Director Dealings / Market Share Purchase |
| 6th Dec 2018 4:11 pm |
RNS |
Axovant FDA meeting feedback |
| 3rd Dec 2018 9:53 am |
RNS |
Total Voting Rights |
| 3rd Dec 2018 7:00 am |
RNS |
Longer term Kymriah efficacy and safety data |
| 23rd Nov 2018 10:41 am |
RNS |
Director Dealings |
| 23rd Nov 2018 7:00 am |
RNS |
Oxford Biomedica form digital framework initiative |
| 9th Nov 2018 7:00 am |
RNS |
Block listing application |
| 1st Nov 2018 2:41 pm |
RNS |
Total Voting Rights |
| 25th Oct 2018 7:00 am |
RNS |
Axovant Doses First Patient with AXO-Lenti-PD |
| 22nd Oct 2018 4:39 pm |
RNS |
Director Dealings / Market Share Purchase |
| 5th Oct 2018 7:00 am |
RNS |
Details of alliance with Orchard Therapeutics |
| 1st Oct 2018 9:41 am |
RNS |
Total Voting Rights |
| 24th Sep 2018 12:20 pm |
RNS |
Director/PDMR Shareholding |
| 20th Sep 2018 10:57 am |
EQS |
Hardman & Co Research: Oxford BioMedica (OXB): Partnering strategy delivering profitability |
| 13th Sep 2018 7:00 am |
RNS |
Oxford BioMedica Interim Results |
| 13th Sep 2018 7:00 am |
RNS |
Oxford BioMedica further capacity expansion |
| 3rd Sep 2018 9:18 am |
RNS |
Total Voting Rights |
| 28th Aug 2018 7:00 am |
RNS |
Kymriah® receives European Commission Approval |
| 22nd Aug 2018 11:58 am |
RNS |
Director/PDMR Shareholding |
| 15th Aug 2018 7:00 am |
RNS |
RNS notice of results OXB |
| 14th Aug 2018 7:15 am |
EQS |
Hardman & Co Research: Oxford BioMedica (OXB): Risk-sharing in cystic fibrosis gene-therapy |
| 13th Aug 2018 10:55 am |
RNS |
Director/PDMR Shareholding |
| 13th Aug 2018 10:48 am |
RNS |
Director/PDMR Shareholding |
| 10th Aug 2018 11:39 am |
RNS |
PDMR Dealings / Market Share Sale |
| 10th Aug 2018 11:36 am |
RNS |
Director Dealings / Market Share Sale and Purchase |
| 8th Aug 2018 2:45 pm |
RNS |
Share Options and LTIPs Granted |
| 6th Aug 2018 7:02 am |
RNS |
Partnership for Cystic Fibrosis Gene Therapy |
